Belgium

 

IK Investments to sell Colisée to EQT Infrastructure

French nursing home operator Colisée is changing hands as IK Investments sells its majority stake to Sweden-based PE firm EQT's infrastructure arm. This is the first large transaction the sector has seen all year.

Biogroup makes first acquisition outside of France – and plans more

Biogroup, France's largest lab group by revenue, has new Belgian shareholders after it acquired family-owned CMA-Medina, its first move outside of the home market. CEO Stephane Eimer tells HBI that the new Franco-Belgian group will make more acquisitions there and abroad.

Curaeos ‘strikes a deal with creditors’

Pan-European dental group Curaeos has reportedly struck a deal with some of its creditors in a move that will lighten the company's debt while transferring a minority stake.

Benelux countries make moves on digital therapy reimbursement

The Netherlands and Belgium are closely following behind Germany in reimbursing digital therapeutics (DTx). Payors in the former are negotiating a strategy while the latter has just seen a rehabilitation app become the first to receive public payment. 

What does a good post-COVID outpatient clinic look like?

Outpatient activity all but came to a standstill as the COVID crisis tightened its grip. A panel of experts comprising Richard Banks, Chief Strategy Officer at international fertility player Virtus Health, Martin Bundschu, Director at Germany-based optical specialist Smile Eyes, former Colosseum Dental CEO Tomas Aubell, and L.E.K. Consulting's global co-head of healthcare Ben Faircloth joined an HBI-365 audience last week to discuss what a good outpatient clinic post-COVID might look like, and how markets have been affected.

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Labs bounce back and eye opportunities

A v-shaped recovery, new markets, new customers, new entrants, new technology and the ear of big government: the HBI 2020 diagnostics panel discussion reveals new opportunities.

Revenue halves for lab groups

HBI understands that lab groups across Europe are seeing revenue drops of 50% despite having extensive participation in COVID-19 testing. 

Find Us